- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04359238
activeDCM - Interventional Clinical Trial of Individualized Activity and Exercise Programs to Improve Outcome in Dilated Cardiomyopathy Guided by Longitudinal Biosensing With Apple Watch (ACTIVE-DCM)
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The recruited subjects (n = 300) receive routine medical care on the day of randomization in our outpatient clinic. Furthermore, an additional blood sample is taken (further blood samples are taken on month 6 and month 12), which contain 9 ml EDTA (for DNA analysis, e.g. whole genome sequencing), 5 ml of PaxGene (for RNA analysis), 7.5 ml of plasma (for example for metabolite and RNA analysis) and 7.5 ml of serum (for example for metabolite and RNA analysis). A detailed medical history is taken during the basic examination. This is followed by detailed physical examination and diagnostics. A routine blood sample is taken to determine the values of electrolytes, NT-ProBNP, hsTnT, creatinine, urea and the blood count. Finally, the patients answer a questionnaire on Quality of Life (MHLFQ: The Minnesota Living with Heart Failure Questionnaire) and Depression (PHQ9).
Two thirds of the patients (n = 200; intervention groups) will regularly participate in an individually designed sports program for a period of 12 months. One third of the participants (n = 100; control group) will not participate in a sports program. As a SmartWatch is required for the study. SmartWatches will be made available to all subjects on the day of recruitment. These are Apple Watches (Series 4), which are provided by Apple Inc. On the Apple Watch, participants have access to an app, that was especially developed by us for the study. This app collects important information about the physical activity and symptoms of the patient (including pulse rate, duration of training, the number of floors, number of steps and ECGs). The Apple Watch is also used to send participants of the intervention group regular notifications about their training status and to remind them of their training.
The participants present themselves 4-6 weeks after recruitment in the department of sports medicine to perform a spiroergometry and a sports medical evaluation. A personalized sports program (depending on the severity of the disease) is created for the subjects of the intervention groups, which consists of strength and endurance training. The sports program will be carried out over a period of 12 months.
All subjects in the intervention groups receive follow-up visits on month 3, month 6, month 9 and month 12. The sports program can be adapted on these dates. The subjects who did not receive a personalized training program presente themselves for the follow-up examination on month 6 and month 12. Unwanted events during the training (including syncope, ICD therapy, injuries) are documented during the follow-up visits.
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Benjamin Meder, Prof. Dr.
- Phone Number: 0049 (0)6221 56-37948
- Email: benjamin.meder@med.uni-heidelberg.de
Study Locations
-
-
Baden-Württemberg
-
Heidelberg, Baden-Württemberg, Germany, 69115
- Recruiting
- Department III of Internal Medicine, University Hospital Heidelberg
-
Contact:
- Benjamin Meder, Prof. Dr.
- Phone Number: 0049 (0)6221 56-37948
- Email: benjamin.meder@med.uni-heidelberg.de
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Diagnosis of non-ischemic, dilated cardiomyopathy (DCM)
- EF ≤ 45%
- NYHA I-III
- Age 18 to 65 years
- The patient understood the study concept and the declaration of consent and signed and dated the declaration of consent
Exclusion Criteria:
- Physical disability that is not compatible with exercise in the study
- Orthopedic diseases such as osteoarthritis or changes in the spine that lead to restrictions that are not compatible with exercise in the study
- Syncope within the past 3 months
- Pregnancy
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: Intervention group with motivation messages
There are 100 patients in the intervention group with automated or observer initiated motivation messages.
They receive an individualized training program with regular notifications about their training status via their SmartWatch.
|
The participants in the intervention group carry out regularly endurance and strength exercises.
|
Active Comparator: Intervention group without motivation messages
There are 100 patients in the intervention group without automated or observer initiated motivation messages.
They receive an individualized training program without regular notifications about their training status via their SmartWatch.
|
The participants in the intervention group carry out regularly endurance and strength exercises.
|
No Intervention: Control group
100 patients are in the control group without an individualized training program.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Maximum oxygen uptake (VO2max)
Time Frame: 12 months
|
Change in maximum oxygen uptake (VO2max) from baseline to 12 months follow-up
|
12 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Quality of life (Patient Reported Outcome)
Time Frame: 12 months
|
Change in quality of life
|
12 months
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Cardiac biomarkers
Time Frame: 12 months
|
Change in Troponin und NTproBNP
|
12 months
|
Cardiac function
Time Frame: 12 months
|
Change in systolic and diastolic cardiac function
|
12 months
|
Arrhythmias
Time Frame: 12 months
|
Change in frequency of arrhythmias
|
12 months
|
Heart failure
Time Frame: 12 months
|
Change in frequency of hospitalization and NYHA class
|
12 months
|
Compliance
Time Frame: 12 months
|
Change in compliance concerning excercise program
|
12 months
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Benjamin Meder, Prof. Dr., University Hospital Heidelberg
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- ACTIVE-DCM
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Heart Failure
-
Tufts Medical CenterMetro West Medical CenterCompletedCongestive Heart Failure | Diastolic Heart Failure | Systolic Heart FailureUnited States
-
Abbott Medical DevicesCompletedHeart Failure | Heart Failure, Diastolic | Heart Failure, Systolic | Heart Failure NYHA Class II | Heart Failure NYHA Class III | Heart Failure With Reduced Ejection Fraction | Heart Failure NYHA Class IV | Heart Failure With Normal Ejection Fraction | Heart Failure; With Decompensation | Heart Failure...United States, Canada
-
Manipal UniversityUnknownHeart Failure | Decompensated Heart Failure | Acute Heart Failure | Diastolic Heart Failure | Systolic Heart FailureIndia
-
VA Eastern Colorado Health Care SystemNational Institute on Aging (NIA)CompletedHeart Failure | Heart Failure, Diastolic | Heart Failure, Systolic | Heart Failure With Reduced Ejection Fraction | Heart Failure With Preserved Ejection Fraction | Heart Failure; With Decompensation | Heart Failure,Congestive | Heart Failure AcuteUnited States
-
University Hospital, MontpellierCompletedHeart Failure | Diastolic Heart Failure | Systolic Heart Failure Stage CFrance
-
Wake Forest UniversityCompletedHeart Failure, Congestive | Heart Failure With Preserved Ejection Fraction
-
Wake Forest UniversityNational Institute on Aging (NIA)CompletedHeart Failure, Congestive | Diastolic Heart FailureUnited States
-
Lancaster General HospitalLouise von Hess Medical Research InstituteEnrolling by invitationDiastolic Heart FailureUnited States
-
Giresun UniversityIstanbul University - Cerrahpasa (IUC)RecruitingHeart Failure | Diastolic Heart Failure | Systolic Heart FailureTurkey
-
University of British ColumbiaCanadian Institutes of Health Research (CIHR); Duke University; St. Paul's Hospital... and other collaboratorsActive, not recruitingHeart Diseases | Heart Failure | Transplant; Failure, Heart | Heart Transplant Failure and Rejection | Heart Failure,Congestive | Transplant FailureCanada, United States
Clinical Trials on Individualized excercise
-
Riphah International UniversityRecruitingPain | Flexibility | Iliotibial Band SyndromePakistan
-
Indonesia UniversityCompleted
-
International Institute of Behavioral MedicinesNot yet recruiting
-
Brigham and Women's HospitalRecruiting
-
Mansoura UniversityCompletedKnee Osteoarthriis and Oxidative StressEgypt
-
Najran UniversityCompletedHealthcare ProfessionalsSaudi Arabia
-
Norwegian University of Science and TechnologySt. Olavs HospitalCompletedPain | Fatigue | Chronic Fatigue Syndrome | Myalgic EncephalomyelitisNorway
-
Riphah International UniversityCompleted
-
University of SevilleCompleted